Pediatr. praxi. 2011;12(1):8-11
Prevalence of reccurent wheeze in infants and toddlers is high. For clinical purposes, reccurent wheeze in children below the age of 5 years
is classified as episodic (viral) or multiple-trigger wheeze. Due to the heterogenity of childhood asthma, different phenotypes of disease
were recognized in preschool and school-age children. In school-age children with persistent asthma, treatment with inhaled corticosteroid
is associated with significant improvements in lung function, bronchial hyperresponsiveness and quality of life. In children younger than
5 years with recurrent wheezing at high-risk for development of asthma preventive inhaled corticosteroid therapy has also multiple clinical
benefits. Appropriate education including asthma management plan and regular assessment of symptoms, lung function and exhaled nitric
oxide enhance good adherence to recommended therapy. In complicated cases multidisciplinary approach is needed.
Published: February 23, 2011 Show citation